clofibric acid has been researched along with Compensatory Hyperinsulinemia in 1 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
Compensatory Hyperinsulinemia: A GLUCOSE-induced HYPERINSULINEMIA, a marker of insulin-resistant state. It is a mechanism to compensate for reduced sensitivity to insulin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Császár, A | 1 |
1 review available for clofibric acid and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
Hypertriglyceridemia, the coronary heart disease risk marker "solved".
Topics: Apolipoprotein C-III; Apolipoproteins C; Clinical Trials as Topic; Clofibric Acid; Coronary Disease; | 2005 |